Publications

Found 753 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kamel H, Gialdini G, Baradaran H, Giambrone AE, Navi BB, Lerario MP, Min JK, Iadecola C, Gupta A.  2017.  Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis.. J Stroke Cerebrovasc Dis. 26(4):863-870.
Kamel H.  2019.  Does Left Atrial Mechanical Dysfunction Contribute to a Thrombogenic Atrial Myopathy? JACC Cardiovasc Imaging.
Kamel H, Merkler AE, Iadecola C, Gupta A, Navi BB.  2019.  Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review.. JAMA Neurol.
Kamel H, Chung CD, Kone GJ, Gupta A, Morris NA, Fink ME, Navi BB.  2018.  Medical Specialties of Clinicians Providing Mechanical Thrombectomy to Patients With Acute Ischemic Stroke in the United States.. JAMA Neurol.
Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MSV.  2015.  Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.. Stroke. 46(11):3208-12.
Kamel H.  2018.  Additional Factors in Considering Patent Foramen Ovale Closure to Prevent Recurrent Ischemic Stroke-Reply.. JAMA Neurol.
Kang Y, Jamison K, Jaywant A, Dams-O'Connor K, Kim N, Karakatsanis NA, Butler T, Schiff ND, Kuceyeski A, Shah SA.  2022.  Longitudinal alterations in gamma-aminobutyric acid (GABAA) receptor availability over ∼ 1 year following traumatic brain injury.. Brain Commun. 4(4):fcac159.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.  2016.  A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Kauwe G, Pareja-Navarro KA, Yao L, Chen JH, Wong I, Saloner R, Cifuentes H, Nana AL, Shah S, Li Y et al..  2024.  KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss.. J Clin Invest. 134(3)
Kauwe G, Pareja-Navarro KA, Yao L, Chen JH, Wong I, Saloner R, Cifuentes H, Nana AL, Shah S, Li Y et al..  2023.  KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss.. bioRxiv.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..  2017.  Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Kawamata H, Manfredi G.  2017.  Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.. J Cell Biol. 216(12):3917-3929.
Ke YD, van Hummel A, Au C, Chan G, Lee WSiang, van der Hoven J, Przybyla M, Deng Y, Sabale M, Morey N et al..  2024.  Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.. Neuron.
Kenny TC, Manfredi G, Germain D.  2017.  The Mitochondrial Unfolded Protein Response as a Non-Oncogene Addiction to Support Adaptation to Stress during Transformation in Cancer and Beyond.. Front Oncol. 7:159.
Kesner AJ, Mozaffarilegha M, Rajamani KThirtamara, Arima Y, Harony-Nicolas H, Hashimotodani Y, Ito HT, Song J, Ikemoto S.  2023.  Hypothalamic Supramammillary Control of Cognition and Motivation.. J Neurosci. 43(45):7538-7546.
Kholmanskikh S, Singh S, M Ross E.  2022.  Activation of RhoC by regulatory ubiquitination is mediated by LNX1 and suppressed by LIS1.. Sci Rep. 12(1):16493.
Khormaee S, Do HT, Mayr Y, Gialdini G, Kamel H, Lyman S, Cross MB.  2018.  Risk of Ischemic Stroke After Perioperative Atrial Fibrillation in Total Knee and Hip Arthroplasty Patients.. J Arthroplasty.
Kim N, O'Sullivan J, Olafson E, Caliendo E, Nowak S, Voss HU, Lowder R, Watson WD, Ivanidze J, Fins JJ et al..  2022.  Cognitive-Motor Dissociation Following Pediatric Brain Injury: What About the Children? Neurol Clin Pract. 12(3):248-257.
Kim E, Woo M-S, Qin L, Ma T, Beltran CD, Bao Y, Bailey JA, Corbett D, Ratan RR, Lahiri DK et al..  2015.  Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke.. J Neurosci. 35(45):15113-26.
Kim S-E, Lei Y, Hwang S-H, Wlodarczyk BJ, Mukhopadhyay S, Shaw GM, M Ross E, Finnell RH.  2018.  Dominant negative GPR161 rare variants are risk factors of human spina bifida.. Hum Mol Genet.
Kim E, Yang J, Park KWoo, Cho S.  2017.  Inhibition of VEGF Signaling Reduces Diabetes-Exacerbated Brain Swelling, but Not Infarct Size, in Large Cerebral Infarction in Mice.. Transl Stroke Res.
Kim E, Cho S.  2016.  Microglia and Monocyte-Derived Macrophages in Stroke.. Neurotherapeutics. 13(4):702-718.
Kobayashi M, Benakis C, Anderson C, Moore MJ, Poon C, Uekawa K, Dyke JP, Fak JJ, Mele A, Park CY et al..  2019.  AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke.. Cell Rep. 28(4):979-991.e6.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.